The course focuses on engineering’s role in commercialization of vaccines and biologics. Biologics are more complex than small molecule drug products and present unique challenges in commercialization. This course includes an overview of vaccines and biologics from historical context, product, process and analytical technologies, immunology, clinical, regulatory and ethical considerations, economics, risk mitigation, and impact on human health.
Biproduct & Bioprocess Engineering
Host University
University of Virginia
Semester
Spring 2024
Course Number
CHE 5456-600
CRN
19656
Credits
3
Discipline
Chemical and Life Science Engineering
Instructor
Michael King, Blair Okita
Course Information
Prerequisites
4th year or higher CHE or BME standing or Instructor Permission